Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Net Margin: 2022-2025

Historic Net Margin for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to 1,899.34%.

  • Centessa Pharmaceuticals' Net Margin rose 23466.00% to 1,899.34% in Q3 2025 from the same period last year, while for Sep 2025 it was -3,597.12%, marking a year-over-year decrease of 518110.00%. This contributed to the annual value of 2,336.54% for FY2024, which is 454120.00% up from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Net Margin is 1,899.34%, which was up 8.81% from 1,745.60% recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Net Margin ranged from a high of 4,490.88% in Q4 2024 and a low of -174.23% during Q1 2025.
  • In the last 3 years, Centessa Pharmaceuticals' Net Margin had a median value of 1,664.69% in 2024 and averaged 1,727.15%.
  • In the last 5 years, Centessa Pharmaceuticals' Net Margin plummeted by 289,598bps in 2023 and then skyrocketed by 305,754bps in 2024.
  • Centessa Pharmaceuticals' Net Margin (Quarterly) stood at 1,959.74% in 2022, then plummeted by 52,639bps to 1,433.35% in 2023, then surged by 305,754bps to 4,490.88% in 2024, then soared by 23,466bps to 1,899.34% in 2025.
  • Its last three reported values are 1,899.34% in Q3 2025, 1,745.60% for Q2 2025, and -174.23% during Q1 2025.